𝔖 Bobbio Scriptorium
✦   LIBER   ✦

25 FRAGMATIC. A randomised phase III clinical trial investigating the effect of FRAGMin® added to standard therapy in patients with lung cancer

✍ Scribed by Macbeth, F.; Noble, S.; Linnane, S.J.


Book ID
118573956
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
46 KB
Volume
57
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES